Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
10/17/2011
Trade Name:
Reyataz
Generic Name or Proper Name (*):
atazanavir
Indications Studied:
Treatment of HIV - 1 infection
Label Changes Summary:
Revised pediatric dosing; Unified dosing for treatment-naive and treatment experienced patients and extended the use of ATV/RTV to treatment-experienced patients weighing 15 to 25 kgNew dosing regimen
Product Labeling:
Labeling
BPCA(B) and PREA(P):
B, P
Sponsor:
Bristol-Myers Squibb
NNPS:
FALSE'
Therapeutic Category:
Antiviral
-
-